STVN vs. SWAV, TFX, PEN, INSP, GMED, PODD, HAE, MMSI, NARI, and GKOS
Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Shockwave Medical (SWAV), Teleflex (TFX), Penumbra (PEN), Inspire Medical Systems (INSP), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE), Merit Medical Systems (MMSI), Inari Medical (NARI), and Glaukos (GKOS). These companies are all part of the "surgical & medical instruments" industry.
Shockwave Medical (NASDAQ:SWAV) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.
Shockwave Medical received 100 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 66.67% of users gave Stevanato Group an outperform vote while only 56.62% of users gave Shockwave Medical an outperform vote.
Shockwave Medical has a net margin of 39.56% compared to Shockwave Medical's net margin of 14.24%. Stevanato Group's return on equity of 47.48% beat Shockwave Medical's return on equity.
Shockwave Medical currently has a consensus target price of $292.29, indicating a potential upside of 46.41%. Given Stevanato Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Shockwave Medical is more favorable than Stevanato Group.
In the previous week, Shockwave Medical had 10 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Shockwave Medical and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.71 beat Shockwave Medical's score of 0.59 indicating that Shockwave Medical is being referred to more favorably in the media.
87.4% of Shockwave Medical shares are held by institutional investors. Comparatively, 10.9% of Stevanato Group shares are held by institutional investors. 3.4% of Shockwave Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Shockwave Medical has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.
Shockwave Medical has higher earnings, but lower revenue than Stevanato Group. Shockwave Medical is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
Summary
Shockwave Medical beats Stevanato Group on 15 of the 18 factors compared between the two stocks.
Get Stevanato Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Stevanato Group Competitors List
Related Companies and Tools
